U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 3C20H24N2O2.2AsH3O4
Molecular Weight 1257.1363
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Quinine arsenate

SMILES

O[As](O)(O)=O.O[As](O)(O)=O.COC1=CC2=C(C=C1)N=CC=C2[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C.COC5=CC6=C(C=C5)N=CC=C6[C@@H](O)[C@@H]7C[C@@H]8CCN7C[C@@H]8C=C.COC9=CC%10=C(C=C9)N=CC=C%10[C@@H](O)[C@@H]%11C[C@@H]%12CCN%11C[C@@H]%12C=C

InChI

InChIKey=CDTYBBCOIQJQRO-INGJVHGESA-N
InChI=1S/3C20H24N2O2.2AsH3O4/c3*1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;2*2-1(3,4)5/h3*3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3;2*(H3,2,3,4,5)/t3*13-,14-,19-,20+;;/m000../s1

HIDE SMILES / InChI

Molecular Formula C20H24N2O2
Molecular Weight 324.4168
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula AsH3O4
Molecular Weight 141.943
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Ammonium dihydrogen arsenate is an inorganic compound that has been considered a potential electro-optic material and has been explored by a number of investigators for modulation purposes. Ammonium arsenate is a cancerogenic substance.

Approval Year

PubMed

PubMed

TitleDatePubMed
Role of autophagy in arsenite-induced neurotoxicity: the involvement of α-synuclein.
2015-03-18
Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1).
2011-12
Fast, quantitative in situ hybridization of rare mRNAs using 14C-standards and phosphorus imaging.
2009-12-15
Effects of different inorganic arsenic species in Cyprinus carpio (Cyprinidae) tissues after short-time exposure: bioaccumulation, biotransformation and biological responses.
2009-12
Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.
2009-10
Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase.
2009-09-01
Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
2009-08
Inorganic arsenic modulates the expression of selenoproteins in mouse embryonic stem cell.
2009-06-01
Effects of inorganic arsenic on the rat and mouse urinary bladder.
2008-12
Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile.
2008-10-01
Arsenite-induced cytotoxicity in dorsal root ganglion explants.
2008-04-15
High dietary fat exacerbates arsenic-induced liver fibrosis in mice.
2008-03
Glutathione-dependent reduction of arsenate by glycogen phosphorylase a reaction coupled to glycogenolysis.
2007-11
Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
2007-11
Redox regulation of RhoA.
2006-12-05
Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration.
2006-11-01
Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells.
2006-07
Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children.
2005-06
Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine.
2004-12
Regulation of cytoplasmic stress granules by apoptosis-inducing factor.
2004-09-01
Human 3'-phosphoadenosine 5'-phosphosulfate synthetase (isoform 1, brain): kinetic properties of the adenosine triphosphate sulfurylase and adenosine 5'-phosphosulfate kinase domains.
2004-04-13
Arsenic induced inhibition of delta-aminolevulinate dehydratase activity in rat blood and its response to meso 2,3-dimercaptosuccinic acid and monoisoamyl DMSA.
2004-03
Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
2003-12
Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes.
2003-12
Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans.
2003-08
Purine nucleoside phosphorylase as a cytosolic arsenate reductase.
2002-11
Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices.
1999-07
Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms.
1998-04
Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression.
1996-11-01
Screening for reproductive toxicity in Fundulus heteroclitus by genetic expression profiling.
1996
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
1994-11-15
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:09:14 GMT 2025
Edited
by admin
on Mon Mar 31 18:09:14 GMT 2025
Record UNII
8C15XFK30P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHININUM ARSENICICUM
HPUS  
Preferred Name English
Quinine arsenate
WHO-DD  
Common Name English
Cinchonan-9-ol, 6?-methoxy-, (8?,9R)-, arsenate (3:2) (salt)
Systematic Name English
Quinine arsenate [WHO-DD]
Common Name English
CHININUM ARSENICICUM [HPUS]
Common Name English
Arsenic acid (H<sub>3</sub>AsO<sub>4</sub>), compd. with (8?,9R)-6?-methoxycinchonan-9-ol (2:3)
Systematic Name English
Classification Tree Code System Code
CFR 21 CFR 310.547
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
NCI_THESAURUS C271
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
208-971-4
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
PRIMARY
NCI_THESAURUS
C90738
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
PRIMARY
EPA CompTox
DTXSID70970226
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
PRIMARY
DAILYMED
8C15XFK30P
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
PRIMARY
CAS
549-59-7
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
PRIMARY
FDA UNII
8C15XFK30P
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
PRIMARY
PUBCHEM
20841765
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
PRIMARY
RXCUI
1309255
Created by admin on Mon Mar 31 18:09:14 GMT 2025 , Edited by admin on Mon Mar 31 18:09:14 GMT 2025
PRIMARY RxNorm
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY